Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women

  • Technology appraisal guidance
  • TA160
  • Published: 
  • Last updated: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence